from july 1984 to september 1987 , 737 patients with aggressive malignant lymphoma ( ml ) were treated by an intensive regimen ( lnh-84 ) comprising three or four courses of doxorubicin , 75 mg/m2 ;
C0281465
lnh-84
C0013089
doxorubicin